Active substance
Results for the substance ribociclib
2 results
About this active substance
Ribociclib is a medication used for the treatment of advanced or metastatic breast cancer that is hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-). It acts as an inhibitor of cyclin-dependent kinases (CDK4/6), slowing the growth of cancer cells.
The medication is taken orally, as directed by a doctor, usually once daily, in combination with other hormonal therapies. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor liver and hematologic function.
Patients should be aware of potential side effects, such as nausea, fatigue, or a decrease in white blood cell count. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, fatigue, and a decrease in white blood cell count. In rare cases, severe reactions such as hepatotoxicity or QT interval prolongation may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, as directed by a doctor, usually once daily, in combination with other hormonal therapies. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor liver and hematologic function.
Patients should be aware of potential side effects, such as nausea, fatigue, or a decrease in white blood cell count. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, fatigue, and a decrease in white blood cell count. In rare cases, severe reactions such as hepatotoxicity or QT interval prolongation may occur. Patients should be informed of these risks before starting treatment.
-
-
KISQALI 200mg film-coated tablets EUROPHARM ORIGINAL MEDICINE